Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
Reck, Martin, Dr, Kaiser, Rolf, MD, Mellemgaard, Anders, MD, Douillard, Jean-Yves, Prof, Orlov, Sergey, Prof, Krzakowski, Maciej, Prof, von Pawel, Joachim, MD, Gottfried, Maya, MD, Bondarenko, Igor, Prof, Liao, Meilin, Prof, Gann, Claudia-Nanette, MD, Barrueco, José, PhD, Gaschler-Markefski, Birgit, PhD, Novello, Silvia, Prof
Published in The lancet oncology (01.02.2014)
Published in The lancet oncology (01.02.2014)
Get full text
Journal Article
Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial
SCAGLIOTTI, Giorgio V, KRZAKOWSKI, Maciej, PAPAI, Zsolt S, KARASEVA, Nina, THONGPRASERT, Sumitra, DALMAU PORTULAS, Elsa, PAWEL, Joachim Von, KE ZHANG, SELARU, Paulina, TYE, Lesley, CHAO, Richard C, GOVINDAN, Ramaswamy, SZCZESNA, Aleksandra, STRAUSZ, Janos, MAKHSON, Anatoly, RECK, Martin, WIERZBICKI, Rafal F, ALBERT, Istvan, THOMAS, Michael, ABRAO MIZIARA, Jose Elias
Published in Journal of clinical oncology (10.06.2012)
Published in Journal of clinical oncology (10.06.2012)
Get full text
Journal Article
Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study
O'Byrne, Kenneth J, Prof, Gatzemeier, Ulrich, MD, Bondarenko, Igor, MD, Barrios, Carlos, MD, Eschbach, Corinna, MD, Martens, Uwe M, MD, Hotko, Yevhen, MD, Kortsik, Cornelius, MD, Paz-Ares, Luis, MD, Pereira, Jose R, MD, von Pawel, Joachim, MD, Ramlau, Rodryg, MD, Roh, Jae-Kyung, Prof, Yu, Chih-Teng, MD, Stroh, Christopher, PhD, Celik, Ilhan, Prof, Schueler, Armin, MS, Pirker, Robert, Prof
Published in The lancet oncology (01.08.2011)
Published in The lancet oncology (01.08.2011)
Get full text
Journal Article
Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non-Small-Cell Lung Cancer
Govindan, Ramaswamy, Szczesna, Aleksandra, Ahn, Myung-Ju, Schneider, Claus-Peter, Gonzalez Mella, Pablo Fernando, Barlesi, Fabrice, Han, Baohui, Ganea, Doina Elena, Von Pawel, Joachim, Vladimirov, Vladimir, Fadeeva, Natalia, Lee, Ki Hyeong, Kurata, Takayasu, Zhang, Li, Tamura, Tomohide, Postmus, Pieter E, Jassem, Jacek, O'Byrne, Kenneth, Kopit, Justin, Li, Mingshun, Tschaika, Marina, Reck, Martin
Published in Journal of clinical oncology (20.10.2017)
Published in Journal of clinical oncology (20.10.2017)
Get full text
Journal Article
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Rittmeyer, Achim, MD, Barlesi, Fabrice, PhD, Waterkamp, Daniel, MD, Park, Keunchil, MD, Ciardiello, Fortunato, MD, von Pawel, Joachim, MD, Gadgeel, Shirish M, MD, Hida, Toyoaki, PhD, Kowalski, Dariusz M, PhD, Dols, Manuel Cobo, MD, Cortinovis, Diego L, PhD, Leach, Joseph, MD, Polikoff, Jonathan, MD, Barrios, Carlos, MD, Kabbinavar, Fairooz, MD, Frontera, Osvaldo Arén, MD, De Marinis, Filippo, MD, Turna, Hande, MD, Lee, Jong-Seok, MD, Ballinger, Marcus, PhD, Kowanetz, Marcin, PhD, He, Pei, PhD, Chen, Daniel S, MD, Sandler, Alan, MD, Gandara, David R, Dr
Published in The Lancet (British edition) (21.01.2017)
Published in The Lancet (British edition) (21.01.2017)
Get full text
Journal Article
Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
RECK, Martin, VON PAWEL, Joachim, MANEGOLD, Christian, ZATLOUKAL, Petr, RAMLAU, Rodryg, GORBOUNOVA, Vera, HIRSH, Vera, LEIGHL, Natasha, MEZGER, Jörg, ARCHER, Venice, MOORE, Nicola
Published in Journal of clinical oncology (10.03.2009)
Published in Journal of clinical oncology (10.03.2009)
Get full text
Journal Article
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
VITTORIO SCAGLIOTTI, Giorgio, PARIKH, Purvish, LEE, Jin S, MELLEMGAARD, Anders, PARK, Keunchil, PATIL, Shehkar, ROLSKI, Janusz, GOKSEL, Tuncay, DE MARINIS, Filippo, SIMMS, Lorinda, SUGARMAN, Katherine P, GANDARA, David, VON PAWEL, Joachim, BIESMA, Bonne, VANSTEENKISTE, Johan, MANEGOLD, Christian, SERWATOWSKI, Piotr, GATZEMEIER, Ulrich, DIGUMARTI, Raghunadharao, ZUKIN, Mauro
Published in Journal of clinical oncology (20.07.2008)
Published in Journal of clinical oncology (20.07.2008)
Get full text
Journal Article
Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer
LARA, Primo N, DOUILLARD, Jean-Yves, FANDI, Abderrahim, SCAGLIOTTI, Giorgio, NAKAGAWA, Kazuhiko, VON PAWEL, Joachim, MCKEAGE, Mark J, ALBERT, Istvan, LOSONCZY, György, RECK, Martin, HEO, Dae-Seog, FAN, Xiaolin
Published in Journal of clinical oncology (01.08.2011)
Published in Journal of clinical oncology (01.08.2011)
Get full text
Journal Article
EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study
Pirker, Robert, Prof, Pereira, Jose R, MD, von Pawel, Joachim, MD, Krzakowski, Maciej, Prof, Ramlau, Rodryg, MD, Park, Keunchil, Prof, de Marinis, Filippo, MD, Eberhardt, Wilfried EE, MD, Paz-Ares, Luis, MD, Störkel, Stephan, Prof, Schumacher, Karl-Maria, MD, von Heydebreck, Anja, PhD, Celik, Ilhan, Prof, O'Byrne, Kenneth J, Prof
Published in The lancet oncology (2012)
Published in The lancet oncology (2012)
Get full text
Journal Article
Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study
Gandara, David R., von Pawel, Joachim, Mazieres, Julien, Sullivan, Richard, Helland, Åslaug, Han, Ji-Youn, Ponce Aix, Santiago, Rittmeyer, Achim, Barlesi, Fabrice, Kubo, Toshio, Park, Keunchil, Goldschmidt, Jerome, Gandhi, Mayank, Yun, Cindy, Yu, Wei, Matheny, Christina, He, Pei, Sandler, Alan, Ballinger, Marcus, Fehrenbacher, Louis
Published in Journal of thoracic oncology (01.12.2018)
Published in Journal of thoracic oncology (01.12.2018)
Get full text
Journal Article
Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer
SEQUIST, Lecia V, VON PAWEL, Joachim, RAMLAU, Rodryg, ARTHUR, Susan, GORBACHEVSKY, Igor, SCHWARTZ, Brian, SCHILLER, Joan H, GARMEY, Edward G, AKERLEY, Wallace L, BRUGGER, Wolfram, FERRARI, Dora, YINPU CHEN, COSTA, Daniel B, GERBER, David E, ORLOV, Sergey
Published in Journal of clinical oncology (20.08.2011)
Published in Journal of clinical oncology (20.08.2011)
Get full text
Journal Article
Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non–Small-Cell Lung Cancer
SCAGLIOTTI, Giorgio, NOVELLO, Silvia, AREN, Osvaldo, CSOLLAK, Maria, ALBERT, Istvan, BARRIOS, Carlos Henrique, GROSSI, Francesco, KIZAKOWSKI, Maciej, CUPIT, Lisa, CIHON, Frank, DIMATTEO, Sandra, HANNA, Nasser, VON PAWEL, Joachim, RECK, Martin, RODRIGUES PEREIRA, José, THOMAS, Michael, ABRAO MIZIARA, José Elias, BALINT, Beatrix, DE MARINIS, Filippo, KELLER, Alan
Published in Journal of clinical oncology (10.04.2010)
Published in Journal of clinical oncology (10.04.2010)
Get full text
Journal Article
Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial
PLUZANSKA, Anna, SZCZESNA, Aleksandra, JANASKOVA, Terezie, VANSTEENKISTE, Johan, STRAUSZ, Janos, MOISEEVICH MANIKHAS, Georgy, VON PAWEL, Joachim, KAUKEL, Eckhard, ROUBEC, Jaromir, DE ROSA, Flavio, MILANOWSKI, Janusz, KARNICKA-MLODKOWSKI, Hanna, PESEK, Milos, SERWATOWSKI, Piotr, RAMLAU, Rodryg
Published in Journal of clinical oncology (20.04.2007)
Published in Journal of clinical oncology (20.04.2007)
Get full text
Journal Article
Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Gemcitabine/Cisplatin Alone or With Sorafenib for the First-Line Treatment of Advanced, Nonsquamous Non–Small-Cell Lung Cancer
PAZ-ARES, Luis G, BIESMA, Bonne, SYRIGOS, Kostas, LE MARIE, Etienne, GOTTFRIED, Maya, VANSTEENKISTE, Johan, ALBEROLA, Vincente, PHILLIP STRAUSS, Uwe, MONTEGRIFFO, Elaine, JIN ONG, Teng, SANTORO, Armando, HEIGENER, David, VON PAWEL, Joachim, EISEN, Timothy, BENNOUNA, Jaafar, LI ZHANG, MEILIN LIAO, YAN SUN, GANS, Steven
Published in Journal of clinical oncology (01.09.2012)
Published in Journal of clinical oncology (01.09.2012)
Get full text
Journal Article
Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial
Hanna, Nasser H, Kaiser, Rolf, Sullivan, Richard N, Aren, Osvaldo Rudy, Ahn, Myung-Ju, Tiangco, Beatrice, Voccia, Isabelle, Pawel, Joachim von, Kovcin, Vladimir, Agulnik, Jason, Gaschler-Markefski, Birgit, Barrueco, José, Sikken, Patricia, Schloss, Charles, Kim, Joo-Hang
Published in Lung cancer (Amsterdam, Netherlands) (01.12.2016)
Published in Lung cancer (Amsterdam, Netherlands) (01.12.2016)
Get full text
Journal Article
Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial
Ramalingam, Suresh S, Prof, Jänne, Pasi A, Prof, Mok, Tony, Prof, O'Byrne, Kenneth, Prof, Boyer, Michael J, Prof, Von Pawel, Joachim, Prof, Pluzanski, Adam, MD, Shtivelband, Mikhail, MD, Docampo, Lara Iglesias, MD, Bennouna, Jaafar, MD, Zhang, Hui, PhD, Liang, Jane Q, PhD, Doherty, Jim P, PhD, Taylor, Ian, PhD, Mather, Cecile B, MS, Goldberg, Zelanna, MD, O'Connell, Joseph, MD, Paz-Ares, Luis, Prof
Published in The lancet oncology (01.11.2014)
Published in The lancet oncology (01.11.2014)
Get full text
Journal Article
Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer
HIRSCH, Fred R, VARELLA-GARCIA, Marileila, VON PAWEL, Joachim, WATKINS, Claire, FLANNERY, Angela, ELLISON, Gillian, DONALD, Emma, KNIGHT, Lucy, PARUMS, Dinah, BOTWOOD, Nicholas, HOLLOWAY, Brian, BUNN, Paul A, FRANKLIN, Wilbur A, DZIADZIUSZKO, Rafal, THATCHER, Nick, CHANG, Alex, PARIKH, Purvish, PEREIRA, José Rodrigues, CIULEANU, Tudor
Published in Journal of clinical oncology (01.11.2006)
Published in Journal of clinical oncology (01.11.2006)
Get full text
Journal Article
Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study
Paz-Ares, Luis, Dr, Mezger, Jörg, Prof, Ciuleanu, Tudor E, Prof, Fischer, Jürgen R, MD, von Pawel, Joachim, MD, Provencio, Mariano, Prof, Kazarnowicz, Andrzej, MD, Losonczy, György, Prof, de Castro, Gilberto, MD, Szczesna, Aleksandra, MD, Crino, Lucio, MD, Reck, Martin, MD, Ramlau, Rodryg, Prof, Ulsperger, Ernst, MD, Schumann, Christian, MD, Miziara, Jose Elias A, MD, Lessa, Álvaro E, MD, Dediu, Mircea, MD, Bálint, Beatrix, PhD, Depenbrock, Henrik, MD, Soldatenkova, Victoria, MSc, Kurek, Raffael, MD, Hirsch, Fred R, Prof, Thatcher, Nick, FRCP, Socinski, Mark A, Prof
Published in The lancet oncology (01.03.2015)
Published in The lancet oncology (01.03.2015)
Get full text
Journal Article
Web Resource
Phase III Study of Oral Compared With Intravenous Topotecan As Second-Line Therapy in Small-Cell Lung Cancer
ECKARDT, John R, VON PAWEL, Joachim, PUJOL, Jean-Louis, PAPAI, Zsolt, QUOIX, Elisabeth, ARDIZZONI, Andrea, POULIN, Ruth, PRESTON, Alaknanda J, DANE, Graham, ROSS, Graham
Published in Journal of clinical oncology (20.05.2007)
Published in Journal of clinical oncology (20.05.2007)
Get full text
Journal Article
An evidence-based review of the incidence of CNS bleeding with anti-VEGF therapy in non-small cell lung cancer patients with brain metastases
Sandler, Alan, Hirsh, Vera, Reck, Martin, von Pawel, Joachim, Akerley, Wallace, Johnson, David H
Published in Lung cancer (Amsterdam, Netherlands) (01.10.2012)
Published in Lung cancer (Amsterdam, Netherlands) (01.10.2012)
Get full text
Journal Article